Residents Forum
RF-Adverse Skin Reaction to Apalutamide: An Emerging Effect
FR-Toxicodermia por apalutamida: una entidad emergente
Read
2703
Timeswas read the article
858
Total PDF
1845
Total HTML
Share statistics
array:24 [ "pii" => "S0001731023001527" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.10.028" "estado" => "S300" "fechaPublicacion" => "2023-04-01" "aid" => "3398" "copyright" => "AEDV" "copyrightAnyo" => "2022" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2023;114:T336-T338" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S0001731022010651" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.03.034" "estado" => "S300" "fechaPublicacion" => "2023-04-01" "aid" => "3349" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2023;114:339-40" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">DERMATOSCOPIA PRÁCTICA</span>" "titulo" => "Claves dermatoscópicas en lentigo maligno extrafacial" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "339" "paginaFinal" => "340" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Dermoscopic Features of Extrafacial Lentigo Maligna" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figura 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 754 "Ancho" => 1005 "Tamanyo" => 85340 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Imagen dermatoscópica. Foco de pigmentación excéntrico (triángulo), retículo típico en periferia (flecha blanca), centro desestructurado con disrupción completa del retículo y líneas blancas (asterisco) y fondo eritematoso con vascularización atípica (flecha negra).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Sarró-Fuente, R. Gamo-Villegas, U. Floristán-Muruzábal" "autores" => array:3 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Sarró-Fuente" ] 1 => array:2 [ "nombre" => "R." "apellidos" => "Gamo-Villegas" ] 2 => array:2 [ "nombre" => "U." "apellidos" => "Floristán-Muruzábal" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022010651?idApp=UINPBA000044" "url" => "/00017310/0000011400000004/v1_202304111712/S0001731022010651/v1_202304111712/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0001731022008109" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.10.021" "estado" => "S300" "fechaPublicacion" => "2023-04-01" "aid" => "3214" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2023;114:336-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">FORO DE RESIDENTES</span>" "titulo" => "FR-Toxicodermia por apalutamida: una entidad emergente" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "336" "paginaFinal" => "338" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "RF-Adverse Skin Reaction to Apalutamide: An Emerging Effect" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1642 "Ancho" => 1674 "Tamanyo" => 673777 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A) Eritrodermia con afectación de la zona anterior del tronco en el primer paciente. B) Rash maculopapular eritematoso con afectación de la zona anterior de tronco y áreas laterales de hombros y brazos en el segundo paciente. C y D) Biopsias cutáneas realizadas en las zonas pectorales de ambos pacientes, en las que se observa un infiltrado predominantemente linfocitario en dermis superficial, asociado a daño de interfase prominente y abundantes queratinocitos apoptóticos (hematoxilina-eosina, x200).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Pons Benavent, S. Porcar Saura, L. Bou Boluda" "autores" => array:3 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Pons Benavent" ] 1 => array:2 [ "nombre" => "S." "apellidos" => "Porcar Saura" ] 2 => array:2 [ "nombre" => "L." "apellidos" => "Bou Boluda" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022008109?idApp=UINPBA000044" "url" => "/00017310/0000011400000004/v1_202304111712/S0001731022008109/v1_202304111712/es/main.assets" ] "asociados" => array:1 [ 0 => array:18 [ "pii" => "S0001731022008109" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.10.021" "estado" => "S300" "fechaPublicacion" => "2023-04-01" "aid" => "3214" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2023;114:336-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">FORO DE RESIDENTES</span>" "titulo" => "FR-Toxicodermia por apalutamida: una entidad emergente" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "336" "paginaFinal" => "338" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "RF-Adverse Skin Reaction to Apalutamide: An Emerging Effect" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1642 "Ancho" => 1674 "Tamanyo" => 673777 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A) Eritrodermia con afectación de la zona anterior del tronco en el primer paciente. B) Rash maculopapular eritematoso con afectación de la zona anterior de tronco y áreas laterales de hombros y brazos en el segundo paciente. C y D) Biopsias cutáneas realizadas en las zonas pectorales de ambos pacientes, en las que se observa un infiltrado predominantemente linfocitario en dermis superficial, asociado a daño de interfase prominente y abundantes queratinocitos apoptóticos (hematoxilina-eosina, x200).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Pons Benavent, S. Porcar Saura, L. Bou Boluda" "autores" => array:3 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Pons Benavent" ] 1 => array:2 [ "nombre" => "S." "apellidos" => "Porcar Saura" ] 2 => array:2 [ "nombre" => "L." "apellidos" => "Bou Boluda" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022008109?idApp=UINPBA000044" "url" => "/00017310/0000011400000004/v1_202304111712/S0001731022008109/v1_202304111712/es/main.assets" ] ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Residents Forum</span>" "titulo" => " RF-Adverse Skin Reaction to Apalutamide: An Emerging Effect" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "T336" "paginaFinal" => "T338" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M. Pons Benavent, S. Porcar Saura, L. Bou Boluda" "autores" => array:3 [ 0 => array:4 [ "nombre" => "M." "apellidos" => "Pons Benavent" "email" => array:1 [ 0 => "martiponsbenavent@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "S." "apellidos" => "Porcar Saura" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "L." "apellidos" => "Bou Boluda" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Clínico Universitario de Valencia, Blasco Ibéñez 17, Valencia 46010, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Arnau de Vilanova, San Clemente 12, Valencia 46015, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "FR-Toxicodermia por apalutamida: una entidad emergente" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1644 "Ancho" => 1682 "Tamanyo" => 675497 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A, Erythroderma on the anterior surface of the trunk of the first patient. B, Erythematous maculopapular rash on the front of the trunk and sides of the shoulders and arms of the second patient. C and D, Skin biopsies of the chest of each patient showed a predominantly lymphocytic infiltrate in the superficial dermis, associated with significant damage at the dermal–epidermal interface and an abundance of apoptotic keratinocytes (hematoxylin–eosin, magnification ×200).</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Apalutamide is an androgen receptor inhibitor approved by the US Food and Drug Administration in 2018 for use against certain prostate cancers. It was approved for use in Europe in March 2021.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a> Skin rashes, hypothyroidism, and bone fractures are among apalutamide's common adverse effects.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Case Descriptions</span><p id="par0010" class="elsevierStylePara elsevierViewall">An 89-year-old man with a history of prostate cancer in treatment with apalutamide for 2 months complained of a skin rash that had first appeared 30 days earlier. The macules and intense peeling started on his chest and spread to involve 80% of his body (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A). Another 89-year-old man with a history of prostate cancer also consulted us for erythematous papules over large areas of his trunk and limbs. This patient had been in treatment with apalutamide for 1 month and the lesions had appeared 7 days before he consulted us. The rash started on his chest and arms and spread upward and downward, sparing areas not exposed to the sun (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>B). Both patients reported intense itching and general discomfort. The first man was admitted to hospital because his overall condition had declined. In both cases, the biopsies demonstrated a lymphocytic infiltrate in the superficial dermis with significant damage at the dermal-epidermal junction and an abundance of apoptotic keratinocytes, suggesting an adverse drug reaction (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>C and 1D). The rashes resolved after apalutamide was stopped and a short course of systemic corticosteroids was prescribed.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Discussion</span><p id="par0015" class="elsevierStylePara elsevierViewall">Reports of adverse skin reactions to apalutamide have been scarce in the literature to date. Such reactions are described in the summary of product characteristics for apalutamide and in a report of a series of 68 Japanese patients in clinical trials prior to approval; the adverse skin effects were described ambiguously as rashes, maculopapular rashes, and generalized rashes.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">1,2</span></a> Such skin lesions developed at one time or another in 51.7% of the patients on apalutamide, and there was a significant correlation between the presence of rashes and drug plasma concentration. In contrast, no correlation was detected between exposure indicated by plasma concentrations and symptom severity, nor between the incidence of lesions and any patient characteristics at baseline.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> The frequency and severity of rashes in the Japanese series was greater than has been observed in patients in other geographic areas. A case of epidermal necrolysis due to apalutamide has been reported.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Other androgen receptor inhibitors, however, have more often been reported to cause adverse skin reactions. Noteworthy are photosensitivity reactions associated with flutamide and bicalutamide, and case reports of a maculopapular rash and acute generalized exanthematous pustulosis related to enzalutamide.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">4,5</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusions</span><p id="par0025" class="elsevierStylePara elsevierViewall">We have presented 2 cases of toxic skin eruptions related to apalutamide, a drug that was recently introduced into our clinical practice; our report shows correlations between histology and symptoms. This drug is expected to be more widely used in the future, and dermatologists should therefore become aware of the characteristics of adverse reactions to it in order to be able to manage both diagnosis and treatment.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Conflicts of Interest</span><p id="par0030" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:8 [ 0 => array:2 [ "identificador" => "xpalclavsec1631428" "titulo" => "Palabras clave" ] 1 => array:2 [ "identificador" => "xpalclavsec1631427" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 3 => array:2 [ "identificador" => "sec0010" "titulo" => "Case Descriptions" ] 4 => array:2 [ "identificador" => "sec0015" "titulo" => "Discussion" ] 5 => array:2 [ "identificador" => "sec0020" "titulo" => "Conclusions" ] 6 => array:2 [ "identificador" => "sec0025" "titulo" => "Conflicts of Interest" ] 7 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1631427" "palabras" => array:4 [ 0 => "Apalutamide" 1 => "Drug-related side effects and adverse reactions" 2 => "Drug eruptions" 3 => "Androgen receptor blockers" ] ] ] ] "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1644 "Ancho" => 1682 "Tamanyo" => 675497 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A, Erythroderma on the anterior surface of the trunk of the first patient. B, Erythematous maculopapular rash on the front of the trunk and sides of the shoulders and arms of the second patient. C and D, Skin biopsies of the chest of each patient showed a predominantly lymphocytic infiltrate in the superficial dermis, associated with significant damage at the dermal–epidermal interface and an abundance of apoptotic keratinocytes (hematoxylin–eosin, magnification ×200).</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Erleada®. Ficha técnica del medicamento. Centro de información online de medicamentos de la Agencia Europea del Medicamento (EMA). Available from: <a target="_blank" href="http://www.ema.europa.eu/">http://www.ema.europa.eu</a> [cited 2021 Aug 4]." ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Skin rash following Administration of Apalutamide in Japanese patients with advanced prostate cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H. Uemura" 1 => "Y. Koroki" 2 => "Y. Iwaki" 3 => "K. Imanaka" 4 => "T. Kambara" 5 => "A. Lopez-Gitlitz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s12894-020-00689-0" "Revista" => array:5 [ "tituloSerie" => "BMC Urol" "fecha" => "2020" "volumen" => "20" "paginaInicial" => "139" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32878613" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A case of toxic epidermal necrolysis associated with apalutamide administration" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N. Sagawa" 1 => "Y. Watanabe" 2 => "Y. Mizuno" 3 => "S. Takanashi" 4 => "T. Watanabe" 5 => "N. Ikeda" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Cutan Immunol Allergy" "fecha" => "2020" "volumen" => "3" "paginaInicial" => "134" "paginaFinal" => "135" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Drug eruption caused by enzalutamide: a case and literature review of androgen receptor inhibitor-related drug eruptions" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "N. Saito-Sasaki" 1 => "Y. Sawada" 2 => "E. Okada" 3 => "M. Nakamura" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Aust J Dermatol" "fecha" => "2018" "volumen" => "59" "paginaInicial" => "e133" "paginaFinal" => "e134" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Enzalutamide induced acute generalized exanthematous pustulosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Alberto" 1 => "M.P. Konstantinou" 2 => "C. Martinage" 3 => "E. Casassa" 4 => "E. Tournier" 5 => "H. Bagheri" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3315/jdcr.2016.1226" "Revista" => array:6 [ "tituloSerie" => "J Dermatol Case Rep" "fecha" => "2016" "volumen" => "10" "paginaInicial" => "35" "paginaFinal" => "38" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27900064" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00017310/0000011400000004/v1_202304111712/S0001731023001527/v1_202304111712/en/main.assets" "Apartado" => array:4 [ "identificador" => "83195" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Foro de Residentes" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011400000004/v1_202304111712/S0001731023001527/v1_202304111712/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731023001527?idApp=UINPBA000044" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 20 | 10 | 30 |
| 2024 October | 152 | 58 | 210 |
| 2024 September | 116 | 34 | 150 |
| 2024 August | 122 | 69 | 191 |
| 2024 July | 99 | 53 | 152 |
| 2024 June | 89 | 62 | 151 |
| 2024 May | 78 | 43 | 121 |
| 2024 April | 84 | 32 | 116 |
| 2024 March | 62 | 51 | 113 |
| 2024 February | 63 | 37 | 100 |
| 2024 January | 54 | 26 | 80 |
| 2023 December | 66 | 12 | 78 |
| 2023 November | 81 | 40 | 121 |
| 2023 October | 84 | 49 | 133 |
| 2023 September | 73 | 29 | 102 |
| 2023 August | 77 | 27 | 104 |
| 2023 July | 119 | 33 | 152 |
| 2023 June | 63 | 30 | 93 |
| 2023 May | 84 | 37 | 121 |
| 2023 April | 131 | 40 | 171 |
| 2023 March | 117 | 61 | 178 |
| 2023 February | 11 | 25 | 36 |
Show all
